Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Scott R. Evans & Anthony D. Harris. (2017) Methods and issues in studies of CRE. Virulence 8:4, pages 453-459.
Read now
Read now
Deirdre Church, Tracie Lloyd, Gisele Peirano & Johann Pitout. (2013) Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates. Scandinavian Journal of Infectious Diseases 45:4, pages 265-270.
Read now
Read now
David M Livermore. (2003) The threat from the pink corner. Annals of Medicine 35:4, pages 226-234.
Read now
Read now
Evangelia Platsouka, Christina Routsi, Olga Paniara, Charis Roussos, Efrosini Dimitriadou & Anastasios Chalkis. (2002) Stenotrophomonas Maltophilia Meningitis, Bacteremia and Respiratory Infection. Scandinavian Journal of Infectious Diseases 34:5, pages 391-392.
Read now
Read now
Articles from other publishers (32)
Maryam Banar, Azin Sattari-Maraji, Ghazal Bayatinejad, Elahe Ebrahimi, Leila Jabalameli, Reza Beigverdi, Mohammad Emaneini & Fereshteh Jabalameli. (2023) Global prevalence and antibiotic resistance in clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis. Frontiers in Medicine 10.
Crossref
Crossref
George Dimopoulos, José Garnacho-Montero, Elisabeth Paramythiotou, Antonio Gutierrez-Pizarraya, Charalambos Gogos, Maria Adriansen-Pérez, Chrysa Diakaki, Dimitrios K. Matthaiou, Garyphalia Poulakou & Karolina Akinosoglou. (2023) Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy?. Diagnostics 13:6, pages 1106.
Crossref
Crossref
Je Eun Song, Sollip Kim, Yee Gyung Kwak, Sunghwan ShinTae-Hyun UmChong Rae ChoJeonghyun Chang. (2023) A 20-year trend of prevalence and susceptibility to trimethoprim/sulfamethoxazole of Stenotrophomonas maltophilia in a single secondary care hospital in Korea. Medicine 102:4, pages e32704.
Crossref
Crossref
H.J. Appaneal, V.V. Lopes, K.L. LaPlante & A.R. Caffrey. (2023) Treatment, clinical outcomes, and predictors of mortality among a national cohort of hospitalized patients with Stenotrophomonas maltophilia infection. Public Health 214, pages 73-80.
Crossref
Crossref
Arun P Nair, Sreethish Sasi, Muna Al Maslamani, Abdullatif Al-khal, Kadavil Chacko, Anand Deshmukh & Mohammed Abukhattab. (2022) Clinical and Epidemiological Characteristics of Stenotrophomonas maltophilia Associated Lower Respiratory Tract Infections in Qatar: A Retrospective Study. Cureus.
Crossref
Crossref
Philippe Guerci, Hugo Bellut, Mokhtar Mokhtari, Julie Gaudefroy, Nicolas Mongardon, Claire Charpentier, Guillaume Louis, Parvine Tashk, Clément Dubost, Stanislas Ledochowski, Antoine Kimmoun, Thomas Godet, Julien Pottecher, Jean-Marc Lalot, Emmanuel Novy, David Hajage & Adrien Bouglé. (2019) Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study. Critical Care 23:1.
Crossref
Crossref
Sunish Shah, Madeline King & Lucia Rose. (2018)
Medical Management of Endocarditis Caused by
Stenotrophomonas maltophilia
: A Case Report
. Journal of Pharmacy Practice 32:6, pages 683-686.
Crossref
Crossref
Ching-Hsun Wang, Jung-Chung Lin, Feng-Yee Chang, Ching-Mei Yu, Wei-San Lin & Kuo-Ming Yeh. (2017) Risk factors for hospital acquisition of trimethoprim–sulfamethoxazole resistant Stenotrophomonas maltophilia in adults: A matched case-control study. Journal of Microbiology, Immunology and Infection 50:5, pages 646-652.
Crossref
Crossref
Rongrong Ma, Yuan Wang, Xiong Zou, Kun Hu, Beibei Sun, Wenhong Fang, Guihong Fu & Xianle Yang. (2017) Pharmacokinetics of sulfamethoxazole and trimethoprim in Pacific white shrimp, Litopenaeus vannamei , after oral administration of single-dose and multiple-dose. Environmental Toxicology and Pharmacology 52, pages 90-98.
Crossref
Crossref
Ching-Hsun Wang, Jung-Chung Lin, Hsin-An Lin, Feng-Yee Chang, Ning-Chi Wang, Sheng-Kang Chiu, Te-Yu Lin, Ya-Sung Yang, Li-Ping Kan, Chin-Hsuan Yang, Ming-Chin Chan & Kuo-Ming Yeh. (2016) Comparisons between patients with trimethoprim–sulfamethoxazole-susceptible and trimethoprim–sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study. Journal of Microbiology, Immunology and Infection 49:3, pages 378-386.
Crossref
Crossref
Elizabeth Hand, Hannah Davis, Ted Kim & Bryson Duhon. (2016)
Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of
Stenotrophomonas maltophilia
infections
. Journal of Antimicrobial Chemotherapy 71:4, pages 1071-1075.
Crossref
Crossref
Violetta Shestivska, Kseniya Dryahina, Jaroslav Nunvář, Kristýna Sovová, Dana Elhottová, Alexandr Nemec, David Smith & Patrik Španěl. (2015)
Quantitative analysis of volatile metabolites released
in vitro
by bacteria of the genus
Stenotrophomonas
for identification of breath biomarkers of respiratory infection in cystic fibrosis.
. Journal of Breath Research 9:2, pages 027104.
Crossref
Crossref
Anthony Ayodeji Adegoke & Anthony I. Okoh. (2014) Antibiogram of Stenotrophomonas maltophilia Isolated From Nkonkobe Municipality, Eastern Cape Province, South Africa. Jundishapur Journal of Microbiology 8:1.
Crossref
Crossref
Yu Lin Wang, Marco R. Scipione, Yanina Dubrovskaya & John Papadopoulos. (2014) Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections. Antimicrobial Agents and Chemotherapy 58:1, pages 176-182.
Crossref
Crossref
Evridiki K. Vouloumanou, Drosos E. Karageorgopoulos, Petros I. Rafailidis, Argyris Michalopoulos & Matthew E. Falagas. (2011) Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence. International Journal of Antimicrobial Agents 38:3, pages 197-216.
Crossref
Crossref
GEORG MASCHMEYER & ULF B. GÖBEL. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
2861
2868
.
STEPHEN H. ZINNER & KENNETH H. MAYER. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
475
486
.
Thomas L. Holland, Christopher W. Woods & Maria Joyce. (2009) Antibacterial Susceptibility Testing in the Clinical Laboratory. Infectious Disease Clinics of North America 23:4, pages 757-790.
Crossref
Crossref
Matthew E. Falagas, Politimi-Eleni Valkimadi, Yu-Tsung Huang, Dimitrios K. Matthaiou & Po-Ren Hsueh. (2008) Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. Journal of Antimicrobial Chemotherapy 62:5, pages 889-894.
Crossref
Crossref
J.I. Garcia Paez & S.F. Costa. (2008) Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. Journal of Hospital Infection 70:2, pages 101-108.
Crossref
Crossref
J. I. Garcia Paez, F. M. Tengan, A. A. Barone, A. S. Levin & S. F. Costa. (2008) Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. European Journal of Clinical Microbiology & Infectious Diseases 27:10, pages 901-906.
Crossref
Crossref
Washington C. WinnJr.Jr., P. Rocco LaSala & Kevin O. Leslie. 2008. Dail and Hammar’s Pulmonary Pathology. Dail and Hammar’s Pulmonary Pathology
228
315
.
Stephan Harbarth. (2007) Should the development of new antibiotics be a public health priority?. Current Opinion in Critical Care 13:5, pages 554-556.
Crossref
Crossref
Shoaib R. Ansari, Hend Hanna, Ray Hachem, Ying Jiang, Kenneth Rolston & Issam Raad. (2007)
Risk factors for infections with multidrug‐resistant
Stenotrophomonas maltophilia
in patients with cancer
. Cancer 109:12, pages 2615-2622.
Crossref
Crossref
D.A. Enoch, C.I. Birkett & H.A. Ludlam. (2007) Non-fermentative Gram-negative bacteria. International Journal of Antimicrobial Agents 29, pages S33-S41.
Crossref
Crossref
A. C. Nicodemo & J. I. Garcia Paez. (2007) Antimicrobial therapy for Stenotrophomonas maltophilia infections. European Journal of Clinical Microbiology & Infectious Diseases 26:4, pages 229-237.
Crossref
Crossref
María Dolores del Toroa, Jesús Rodríguez-Baño, Luis Martínez-Martínez, Álvaro Pascual, Ramón Pérez-Cano, Evelio J. Perea & Miguel Ángel Muniain. (2006) Características epidemiológicas, clínicas y pronósticas de la infección por Stenotrophomonas maltophilia. Enfermedades Infecciosas y Microbiología Clínica 24:1, pages 4-9.
Crossref
Crossref
Maria Joyce & Christopher W Woods. (2004) Antibacterial susceptibility testing in the clinical laboratory. Infectious Disease Clinics of North America 18:3, pages 401-434.
Crossref
Crossref
Rafael Cantón, Sylvia Valdezate, Ana Vindel, Begoña Sánchez Del Saz, Luis Maíz & Fernando Baquero. (2003)
Antimicrobial susceptibility profile of molecular typed cystic fibrosis
Stenotrophomonas maltophilia
isolates and differences with noncystic fibrosis isolates
. Pediatric Pulmonology 35:2, pages 99-107.
Crossref
Crossref
Evangelos J. Giamarellos-Bourboulis, Lazaros Karnesis, Irene Galani & Helen Giamarellou. (2002)
In Vitro Killing Effect of Moxifloxacin on Clinical Isolates of
Stenotrophomonas maltophilia
Resistant to Trimethoprim-Sulfamethoxazole
. Antimicrobial Agents and Chemotherapy 46:12, pages 3997-3999.
Crossref
Crossref
Evangelos J Giamarellos-Bourboulis, Lazaros Karnesis & Helen Giamarellou. (2002) Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia. Diagnostic Microbiology and Infectious Disease 44:3, pages 259-263.
Crossref
Crossref
Rahmet Caylan, Kemalettin Aydin & Iftihar Koksal. (2002)
Meningitis Caused by
Stenotrophomonas Maltophilia
: Case Report and Review of the Literature
. Annals of Saudi Medicine 22:3-4, pages 216-218.
Crossref
Crossref